Women's health – a hot area at the moment for many generic companies – is one of Bayer Healthcare's key therapy areas of focus; and there is plenty of room for more innovation-based R&D in this space, according to UK & Ireland chief Dr Alexander Moscho.
"It is worrying that big women's health players appear to be vacating or cutting back in this development area," the...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
